Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 760.9M | 714.1M | 703.2M | 669.7M |
| Cost of revenue | 122.2M | 115.1M | 103.3M | 99.3M |
| Gross profit | 638.7M | 599.0M | 599.8M | 570.4M |
| Operating expense | ||||
| Research & development | 237.3M | 220.1M | 213.7M | 191.2M |
| Selling general and admin | 424.9M | 405.3M | 395.8M | 387.9M |
| Other operating expenses | — | — | — | — |
| Operating income | -23.5M | -26.4M | -9.7M | -8.6M |
| Non operating interest income | ||||
| Income | 18.3M | 20.6M | 21.8M | 21.8M |
| Expense | 227K | 644K | 949K | 936K |
| Other income expense | -11K | -3.4M | 1.8M | -1.6M |
| Pretax income | -5.5M | -9.9M | 13.0M | 10.6M |
| Tax provision | -2.2M | 11.9M | 8.0M | 2.5M |
| Net income | -3.3M | -21.8M | 5.0M | 8.1M |
| Basic EPS | -0.1 | -0.4 | 0.1 | 0.2 |
| Diluted EPS | -0.1 | -0.4 | 0.1 | 0.2 |
| Basic average shares | 52.7M | 52.2M | 51.7M | 51.4M |
| Diluted average shares | 52.7M | 52.2M | 52.2M | 51.8M |
| EBITDA | 29.1M | 20.7M | 43.5M | 37.6M |
| Net income from continuing op. | -3.3M | -21.8M | 5.0M | 8.1M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |